Actively Recruiting
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
Led by National Cancer Institute (NCI) · Updated on 2026-05-13
700
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
BACKGROUND * This protocol acknowledges that it is in the interest of the NIH and ROB, as well as our participants, to continue to follow those who have been treated with radiotherapy at ROB and are not otherwise eligible for current active research protocols. * It also provides a mechanism for the correlation and interpretation of disparate data for research into the long term side effects and outcomes for a variety of disease entities and treatments, such as combined modality treatment, MoAb, PDT, radiation modifiers, intraoperative radiotherapy, etc. OBJECTIVE -The primary objective of this protocol is to assess the late effects of treatment and the natural history of disease through collection of data from any standard procedures performed as part of follow up care on participants previously treated with radiotherapy. ELIGIBILITY -Participants who received radiation therapy. DESIGN * This is a natural history protocol in which long-term follow up data will be collected from participants who received radiation therapy. * It will be made clear to participants in the consent form, that data collected during their follow-up may be used anonymously for publications concerning the natural history of disease processes and long-term effects of treatment.
CONDITIONS
Official Title
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The Radiation Oncology Branch investigator believes it is in the participant's and NCI/ROB's best interest for follow-up care.
- Participant is able to provide informed consent.
- Participant has a primary physician in the community for record keeping and follow-up.
- Participants have received radiotherapy.
- Participants are 18 years of age or older.
You will not qualify if you...
- Participants currently enrolled in an interventional research protocol at NIH at the time of enrollment.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
Research Team
T
Theresa C Cooley Zgela, R.N.
CONTACT
K
Kevin A Camphausen, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here